Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA GSK PHARMA ALEMBIC PHARMA/
GSK PHARMA
 
P/E (TTM) x 19.5 -80.6 - View Chart
P/BV x 7.5 12.0 62.9% View Chart
Dividend Yield % 0.5 1.3 38.3%  

Financials

 ALEMBIC PHARMA   GSK PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
GSK PHARMA
Mar-19
ALEMBIC PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6643,595 18.5%   
Low Rs4121,253 32.9%   
Sales per share (Unadj.) Rs208.7184.7 113.0%  
Earnings per share (Unadj.) Rs31.026.3 117.9%  
Cash flow per share (Unadj.) Rs37.129.2 127.3%  
Dividends per share (Unadj.) Rs5.5020.00 27.5%  
Dividend yield (eoy) %1.00.8 123.9%  
Book value per share (Unadj.) Rs144.2126.3 114.2%  
Shares outstanding (eoy) m188.52169.40 111.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.613.1 19.6%   
Avg P/E ratio x17.492.2 18.8%  
P/CF ratio (eoy) x14.583.1 17.4%  
Price / Book Value ratio x3.719.2 19.4%  
Dividend payout %17.776.1 23.3%   
Avg Mkt Cap Rs m101,461410,626 24.7%   
No. of employees `000NA5.0 0.0%   
Total wages/salary Rs m7,4675,372 139.0%   
Avg. sales/employee Rs ThNM6,306.7-  
Avg. wages/employee Rs ThNM1,083.1-  
Avg. net profit/employee Rs ThNM898.0-  
INCOME DATA
Net Sales Rs m39,34731,281 125.8%  
Other income Rs m941,023 9.2%   
Total revenues Rs m39,44132,304 122.1%   
Gross profit Rs m8,7366,009 145.4%  
Depreciation Rs m1,152486 237.1%   
Interest Rs m1846 3,068.3%   
Profit before tax Rs m7,4936,540 114.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0287 0.0%   
Tax Rs m1,5682,373 66.1%   
Profit after tax Rs m5,8444,454 131.2%  
Gross profit margin %22.219.2 115.6%  
Effective tax rate %20.936.3 57.7%   
Net profit margin %14.914.2 104.3%  
BALANCE SHEET DATA
Current assets Rs m19,57720,061 97.6%   
Current liabilities Rs m14,89614,543 102.4%   
Net working cap to sales %11.917.6 67.4%  
Current ratio x1.31.4 95.3%  
Inventory Days Days9057 158.1%  
Debtors Days Days4514 322.6%  
Net fixed assets Rs m27,09714,343 188.9%   
Share capital Rs m3771,694 22.3%   
"Free" reserves Rs m26,81119,704 136.1%   
Net worth Rs m27,18821,398 127.1%   
Long term debt Rs m4,9932 249,650.0%   
Total assets Rs m47,77839,113 122.2%  
Interest coverage x41.71,091.0 3.8%   
Debt to equity ratio x0.20 196,485.4%  
Sales to assets ratio x0.80.8 103.0%   
Return on assets %12.611.4 110.6%  
Return on equity %21.520.8 103.3%  
Return on capital %23.631.9 73.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,453534 3,642.8%   
Fx outflow Rs m6,0657,091 85.5%   
Net fx Rs m13,388-6,557 -204.2%   
CASH FLOW
From Operations Rs m8,1203,994 203.3%  
From Investments Rs m-7,556-1,433 527.1%  
From Financial Activity Rs m590-3,584 -16.5%  
Net Cashflow Rs m1,153-1,023 -112.7%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 2.9 10.2 28.4%  
FIIs % 9.1 23.8 38.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 15.4 90.3%  
Shareholders   49,328 102,036 48.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SHASUN PHARMA  WYETH  TORRENT PHARMA  SUVEN LIFE SCIENCES  DR. REDDYS LAB  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views on News

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 15, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS